Gene: ERC2
Official Full Name: ELKS/RAB6-interacting/CAST family member 2provided by HGNC
Gene Summary: This gene encodes a protein that belongs to the Rab3-interacting molecule (RIM)-binding protein family. Members of this protein family form part of the cytomatrix at the active zone (CAZ) complex and function as regulators of neurotransmitter release. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28415 | ERC2 Knockout cell line (HEK293) | Human | ERC2 | 1:3~1:6 | Negative | Online Inquiry |
ERC2 Gene Knockout Cell Lines are advanced biological reagents engineered to facilitate the precise study of the ERC2 gene's function and its role in cellular processes. These cell lines have been meticulously developed using CRISPR-Cas9 technology to achieve specific genomic alterations, allowing researchers to investigate the effects of ERC2 gene deletion on various biological pathways, cellular behaviors, and disease models.
The primary function of ERC2 Gene Knockout Cell Lines lies in their ability to serve as a versatile platform for gene function studies, drug screening, and the development of gene therapies. By removing the ERC2 gene, researchers can analyze the resulting phenotypic changes, elucidate pathways implicated in various diseases, and potentially identify therapeutic targets. The mechanisms involved in this process often include perturbations in cellular signaling networks, changes in gene expression profiles, and alterations in cell proliferation and differentiation, which are critical for a deeper understanding of both basic biology and pathological conditions.
The scientific importance of these cell lines is underscored by their applications in research settings, particularly in studies focused on neurodevelopmental disorders and cancer. They provide invaluable insights that contribute to the understanding of how disruptions in gene function can lead to disease, thereby playing a crucial role in the ongoing development of targeted therapies and personalized medicine strategies.
Compared to traditional cell lines, ERC2 Gene Knockout Cell Lines offer unique advantages: they provide a specific, reproducible model for studying the absence of ERC2 function without the confounding effects often seen in partial knockdowns. Furthermore, their ease of use and adaptability in various assay formats enhance their appeal among researchers.
For clinicians and researchers alike, these cell lines are pivotal tools that not only streamline experimental workflows but also support the rapid advancement of biomedical research. They are designed with the end-user in mind, ensuring that both novice and expert scientists can access high-quality resources for their investigations.
At [Your Company Name], we specialize in delivering expertly crafted biological products that empower scientists in their pursuit of knowledge. Our commitment to quality and innovation is reflected in the development of ERC2 Gene Knockout Cell Lines, making them an essential addition to any research toolkit.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.